Kim Blackwell

Dr. Blackwell is currently the Chief Medical Officer of Tempus Labs, a company applying artificial intelligence to advance precision medicine. Prior to Tempus, she worked at Eli Lilly, where she was Vice President of Early Phase Oncology and Immuno-oncology. Before joining the drug development industry, Dr. Blackwell was a Professor of Medicine and Assistant Professor of Radiation Oncology at Duke University, where she directed the Women’s Cancer Program, Strategic Collaborations, and the Precision Medicine Initiative for the Duke Cancer Institute. She received her M.D. from Mayo Clinic Medical School, followed by training in internal medicine and hematology-oncology at Duke University.